Health-Related Quality of Life Outcomes and Bleeding Rates Among Patients With Severe Hemophilia A on Emicizumab
Clinical trial NCT06104826 · UNKNOWN
Trial details
- NCT number
- NCT06104826
- Sponsor
- Newark Beth Israel Medical Center
- Status
- UNKNOWN
- Study type
- OBSERVATIONAL
- Start date
- 2023-12-01
- Primary completion
- 2024-12-01
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.